Novo Nordisk CEO to step down after 16 years
Posted September 01, 2016 7:00 am
COPENHAGEN, Denmark (AP) - Novo Nordisk says its CEO, Lars Rebien Soerensen, is stepping down at the end of the year after 16 years in charge at the Danish drug maker.
The company said Thursday that Executive Vice President Lars Fruergaard Joergensen will replace 61-year-old Soerensen on Jan. 1, 2017.
Novo Nordisk, one of the world's leading makers of diabetes medicines, has expanded under Soerensen's leadership, with a five-fold increase in revenue since 2000.
But the company's share price has dropped 15 percent since early August, when the company slashed its full-year growth forecast, citing intensifying competition in the United States.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.